Effect of rimonabant on weight reduction and cardiovascular risk

被引：16
|
作者：
Hirschel, B [1 ]
机构：
[1] Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva, Switzerland
来源：
LANCET | 2005年 / 366卷 / 9483期
关键词：
D O I：
10.1016/S0140-6736(05)67019-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：369 / 369
页数：1
相关论文
共 50 条
  • [41] Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors
    Jenkins, David J. A.
    Boucher, Beatrice A.
    Ashbury, Fredrick D.
    Sloan, Margaret
    Brown, Patrick
    El-Sohemy, Ahmed
    Hanley, Anthony J.
    Willett, Walter
    Paquette, Melanie
    de Souza, Russell J.
    Ireland, Christopher
    Kwan, Natalie
    Jenkins, Amy
    Pichika, Sathish C.
    Kreiger, Nancy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (09) : 1103 - 1112
  • [42] Effect of Weight Loss on the Cardiovascular Risk Profile of Obese Patients with Psoriasis
    Jensen, Peter
    Zachariae, Claus
    Christensen, Robin
    Geiker, Nina R. W.
    Schaadt, Bente K.
    Stender, Steen
    Astrup, Arne
    Hansen, Peter R.
    Skov, Lone
    ACTA DERMATO-VENEREOLOGICA, 2014, 94 (06) : 691 - 694
  • [43] Effect of Rimonabant on Body Weight and Composition of Adults with Prader Willi Syndrome.
    Motaghedi, R.
    Lipman, E. G.
    Hogg, J. E.
    Christos, P. J.
    Vogiatzi, M. G.
    Angulo, M. A.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [44] Is rimonabant a safe and effective therapy for sustained weight loss and improved cardiometabolic risk factors?
    Tonstad, S
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (07): : 364 - 365
  • [45] Is rimonabant a safe and effective therapy for sustained weight loss and improved cardiometabolic risk factors?
    Serena Tonstad
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 364 - 365
  • [46] Ramipril and cardiovascular risk reduction
    Nichols, WW
    Schuler, B
    O'Rourke, MF
    CIRCULATION, 2002, 105 (25) : A194 - A194
  • [47] Cardiovascular risk reduction in the pharmacy
    Bouwer, Annatjie
    SA PHARMACEUTICAL JOURNAL, 2011, 78 (08) : 27 - 30
  • [48] Hypertriglyceridemia and cardiovascular risk reduction
    Jacobson, Terry A.
    Miller, Michael
    Schaefer, Ernst J.
    CLINICAL THERAPEUTICS, 2007, 29 (05) : 763 - 777
  • [49] Niacin for Reduction of Cardiovascular Risk
    Hu, Miao
    Tomlinson, Brian
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1941 - 1942
  • [50] Salt reduction and cardiovascular risk
    Michael H Alderman
    Journal of Human Hypertension, 1999, 13 : 645 - 645
12345